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Cyclodextrin-based multivalent glycodisplays:
covalent and supramolecular conjugates to assess
carbohydrate–protein interactions†
A´lvaro Martı´nez,a Carmen Ortiz Mellet*a and Jose´ M. Garcı´a Ferna´ndez*b
Covalent attachment of biorecognizable sugar ligands in several copies at precise positions of
cyclomaltooligosaccharide (cyclodextrin, CD) macrocycles has proven to be an extremely flexible strategy
to build multivalent conjugates. The commercial availability of the native CDs in three diﬀerent
sizes, their axial symmetry and the possibility of position- and face-selective functionalization allow a
strict control of the valency and spatial orientation of the recognition motifs (glycotopes) in low,
medium, high and hyperbranched glycoclusters, including glycodendrimer–CD hybrids. ‘‘Click-type’’
ligation chemistries, including copper(I)-catalyzed azide–alkyne cycloaddition (CuAAC), thiol–ene
coupling or thiourea-forming reactions, have been implemented to warrant full homogeneity of
the adducts. The incorporation of diﬀerent glycotopes to investigate multivalent interactions in
heterogeneous environments has also been accomplished. Not surprisingly, multivalent CD
conjugates have been, and continue to be, major actors in studies directed at deciphering the structural
features ruling carbohydrate recognition events. Nanometric glycoassemblies endowed with the
capability of adapting the inter-saccharide distances and orientations in the presence of a receptor
partner or capable of mimicking the fluidity of biological membranes have been conceived
by multitopic inclusion complex formation, rotaxanation or self-assembling. Applications in the
fields of sensors, site-specific drug and gene delivery or protein stabilization attest for the maturity of
the field.
1. Introduction
The ability of carbohydrate ligands to participate in biological
recognition processes is strongly related to their density and
presentation mode. Many synthetic polyconjugates with various
copies of the individual recognition motif onto molecular,
dendritic, polymeric, self-assembled or nanometric scaﬀolds
have been developed aiming at mimicking and matching the
arrangement of their complementary protein receptors (lectins)
in the natural mode of aﬃnity enhancement.1–6 A consistent
body of results has been accumulated over the last twenty years,
amply demonstrating that ligand multivalency increases protein-
binding avidities dramatically. The geometrical characteristics
of the multivalent assembly also exert an important influence
that is dependent on the glycotope, the lectin partner and
the respective densities.7 Adjusting the architectural
parameters, including ligand placing, orientation and active
positioning is critical to maximize the activities of multivalent
glycoconstructs. Well-defined molecular platforms allowing a
precise control of these features have contributed decisively
to unravel the mechanisms at work, leading eventually to
biotechnological8,9 or therapeutic applications.10–12 Among
them, the multivalent cyclooligosaccharides of the cyclodextrin
family (CDs) occupy a prominent position, their development
being historically related to progress and maturation of the
multivalency concept.13–16 The close relationship between
molecular features and supramolecular status of these com-
pounds makes them particularly well-suited not only to opti-
mize carbohydrate–protein interactions, but also to further
programming the system to perform recognition-dependent
specific tasks.
CDs are naturally occurring cyclic oligosaccharides derived
from starch composed of six, seven or eight a(1–4)-linked
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glucopyranose units (a, b and gCD, respectively). They feature a
toroidal truncated-cone topology in which the glucose elements,
in the 4C1 chair conformation, orient the hydroxyls to the outer
space flanking the upper (OH-6) and lower rims (OH-2 and OH-3),
keeping an axial symmetric arrangement. Diﬀerences in the
steric accessibility and acidity of the three types of hydroxyls in
the molecule have been taken into account to conceive eﬃcient
position-selective and face-selective chemical functionalization
methodologies.17–27 A variety of multivalent conjugates with
diverse architectures becomes then accessible through appro-
priate ligation chemistries (Fig. 1).
The inner nanometric cavity of the cyclooligosaccharide
core, comparatively hydrophobic, remains essentially unaltered
after conjugation, preserving the distinct inclusion capabilities
of CDs already profusely exploited by the pharmaceutical
industry for drug encapsulation purposes.28–33 Multivalent
CDs can be thus considered as hybrid ligand–host mole-
cules bearing two orthogonal recognition domains, namely
the glycoligand display and the hydrophobic cavity. The
potential of such unique arrangement for receptor-mediated
site-specific delivery of active guests or probes was soon recog-
nized and has been a permanent motivation for the design
and optimization of multivalent CD conjugates.34 Interestingly,
this ligand–host duality can also be exploited to build
guest-mediated supramolecular assemblies, e.g. through
inclusion complex formation or rotaxanation (Fig. 2A and B),
thereby altering the formal valency and the dynamic rearrange-
ment of the biological association. The spontaneous organiza-
tion of CD conjugates into well-defined structures held
together by non-covalent interactions can also be promoted
by judicious installation of additional functional elements
in the structure via covalent or supramolecular approaches,
which typically seek at imparting amphiphilicity, thereby
broadening the range of available CD-based multivalent
systems and the potential for more sophisticated applications
(Fig. 2C).35,36
This review outlines the potential of CDs to build multi-
valent systems through molecular diversity- and purpose-
oriented strategies. The contribution of CD conjugates to
improve our knowledge on the mechanisms involved in multi-
valent interactions and the way this information can be opti-
mized and directly applied in the design of molecular and
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macromolecular devices will be highlighted. For the sake of
congruity, the classical ‘‘static’’ glycocluster-type systems are
revisited and updated, but the accent will be placed in the
opportunity of combining multivalency, host–guest and self-
organization properties to conceive multifunctional ‘‘dynamic’’
CD nanometric glycoassemblies.
2. Position-selective multivalent
cyclodextrin conjugates
Selective mono-(O-6)-p-toluenesulfonylation (tosylation) of
commercial CDs by reaction with p-toluenesulfonyl chloride
or other p-toluenesulfonyl-transferring reagents under basic
catalysis is a classical methodology to access single-position
functionalized derivatives.37–42 Tosylation at O-6I is favored on
steric grounds and, in the particular case of bCD when using
aqueous media, by inclusion of the sulfonylating reagent in the
cavity. This pathway competes, however, with tosylation at
the more acidic O-2 position, which strongly complicates the
purification step and represents a serious handicap for the final
yield. This drawback has been largely mitigated by pre-
formation of a sandwich-type complex with Cu2+ under strict
pH control.25 The 6I-O-tosyl functionality can be replaced by
other functional groups through classical nucleophilic displa-
cement reactions, allowing the implementation of diﬀerent
strategies for the construction of CD–glycodendron or –glyco-
dendrimer conjugates (see Fig. 1A for a schematic representation).
Simultaneous regioselective diﬀerentiation of O-6I and O-6IV
positions in bCD has also become accessible after di-(isobutyl)-
aluminium (DIBAL)-promoted di-debenzylation of the fully
benzylated derivative,20 which provides an excellent scaﬀold
for the construction of di-branched prototypes with a controlled
separation between the coating sugar ligands (se Fig. 1B for a
schematic representation).
2.1. CD-glycodendrimer hybrids
In a seminal work published in 1992, Lancelon-Pin and Driguez
reported the synthesis of monosubstituted divalent derivatives
by conjugation of carboxylic acid-armed b-D-galactopyranosyl
(bGal) and a-D-mannopyranosyl (aMan) dendrons (4 and 5) with
mono-(C-6)-amino bCD.43 The branching unit was prepared
from dibromide precursor 1 by nucleophilic displacement with
the per-O-acetylated thiosugars 2 and 3, after in situ generation
of the corresponding thiolates with cesium carbonate
(Scheme 1). Preliminary studies showed specific recognition
of the galacto- and manno-conjugates (6 and 7) by Ricinus
communis and concanavalin A (Con A) lectin, respectively.
The prototype consisting of a CD moiety connected through
a single primary position to the focal point of a glycodendritic
structure, e.g. through a thiourea bridge, seemed to be parti-
cularly well adapted for the design of molecular shuttles for site
specific drug delivery. First, the access of the drug guest to the
CD cavity should not be much altered after monosubstitution,
whereas conjugation is expected to increase water solubility.
Second, the peripheral multivalent sugar display will remain
fully accessible to participate in recognition phenomena by
specific receptors at the cell surface, imparting targeting
capabilities through the formation of drug:CD:lectin ternary
complexes (Scheme 2).
In a collaborative work, the groups of Defaye, Garcı´a Ferna´ndez
and Ortiz Mellet provided a proof of concept for the above
hypothesis. By exploiting the thiourea-forming coupling reac-
tion44,45 between isothiocyanate-armed glycodendrons and
Fig. 2 Examples of self-assembled multivalent architectures from CD–glycoligand
(in red) conjugates promoted by either a guest partner or a functional moiety
(in orange): (A) multitopic inclusion complex; (B) polyrotaxane; (C) micelle, vesicle
or nanocomplex.
Fig. 1 Structure of the CDs and examples of multivalent conjugate architectures
(the bCD platform is represented): (A) CD–glycodendrimer conjugate; (B) posi-
tion-selective CD-bis conjugate; (C) face-selective glycocluster; (D) dual-face
glycocluster; (E) hyperbranched glycocluster.
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mono-(C-6)-amino bCD, they prepared a series of aMan-coated
conjugates comprising valencies between 2 and 6 (Fig. 3).46,47
Enzyme-linked lectin assay (ELLA) comparative binding studies
against the mannose-specific lectin Con A,48–50 using mono-
valent conjugates and bCD-devoid glycodendrons as control, let
confirm that (i) increasing the aMan valency significantly
enhanced Con A binding avidity, (ii) the presence of the CD
moiety did not interfere with lectin recognition and (iii) con-
jugation was not detrimental regarding bCD inclusion capabil-
ities. Interestingly, they additionally found that the internal
structure of the glycodendrimer had a strong impact on the
magnitude of the multivalent eﬀect. Thus, grouping the ligand
units in triads was particularly favourable.
Based on the above commented results, the authors
designed a molecular device purposely conceived to complex
the antimitotic drug docetaxel (Taxote`res),51 consisting of a
ditopic bCD host expanding the distance between the two
phenyl rings in the drug and an appended hexavalent glyco-
dendrimer incorporating two trimeric aMan subunits (Fig. 4).
The system was shown to specifically bind at the membrane of
mouse alveolar macrophages via the macrophage mannose
receptor (MMR).47
Hattori and co-workers developed a chemoenzymatic
approach for the preparation of monosubstituted CD derivatives
that incorporated the sialoglycopeptide (SGP) branched oligo-
saccharide as a multivalent biorecognizable ligand (Scheme 3).52
They first attached a unit of 4-hydroxyphenyl b-D-glucopyrano-
side (arbutin) at a single primary position onto bCD and then
employed the endo-b-N-acetylglucosaminidase of Mucor hiemalis
(Endo-M) and SGP from hen egg yolk to obtain the transglyco-
sylation product. The presence of the arbutin moiety in the bCD
acceptor warranted a high yield (65–67%) in the last step and,
Scheme 1 Synthesis of monosubstituted divalent bCD conjugates according to
Lancelon-Pin and Driguez.43
Scheme 2 Schematic representation of CD–glycodendrimer conjugates (their
construction by using the thiourea-forming reaction is shown) and their involve-
ment in the formation of ternary complexes with drug and lectin partners.
Fig. 3 Set of aMan-coated bCD–glycodendrimer conjugates prepared by Defaye,
Garcı´a Ferna´ndez and Ortiz Mellet for comparative binding to Con A lectin.46,47
Fig. 4 Dimeric hexavalent CD–glycodendrimer conjugate design for MMR-
mediated delivery of docetaxel (Taxote`res) to macrophages.47
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moreover, enhanced the stability of the corresponding inclu-
sion complexes with the anticancer drug doxorubicin (DXR).
More recently, Seeberger53 and co-workers implemented the
copper(I)-catalyzed alkyne–azide 1,3-dipolar cycloaddition
(CuAAC), the paradigmatic ‘‘click’’-type reaction,54–57 for the
conjugation of an azide-armed glycodendrimer incorporating
nine copies of per-O-acetylated bGal (8) and a monosubstituted
bCD derivative equipped with a terminal alkyne group (9)
(Scheme 4). The fully unprotected adduct 10 acted as a
target-driven delivery platform to hepatocytes (HepG2 cell line)
expressing the asialoglycoprotein receptor (ASGPr). In agree-
ment, the corresponding complex with DXR produced chemically
induced apoptosis in this cell line. The bGal-mediated character
of the delivery process was confirmed by using an analogous
nonavalent aMan conjugate as negative control.
The promise of CD–glycodendrimer conjugates for drug
glycotargeting led Benito and co-workers to explore alternative
synthetic routes based on solid-phase strategies. A successful
resin-assisted procedure, employing Ellman safety-catch
sulfonamide linker, was developed.58 The methodology is
exemplified in Scheme 4 for the preparation of a hexa-aMan
derivative. Fmoc-protected glycine (FmocGlyOH) 11 was first
anchored to the solid support, followed by peptide coupling
with diBoc-protected N-bis(2-aminoethyl)glycine 12 and
TFA-catalyzed hydrolysis of the carbamate groups (-13).
Thiourea-coupling of the resulting diamine with the trivalent
isocyanate-armed dendron 14 provided a hexavalent glycoden-
drimer attached to the resin (-15). Linker activation by reac-
tion with iodoacetonitrile and diisopropyl ethyl amine (DIPEA)
followed by addition of mono-(C-6)-amino-bCD transferred the
multivalent branch from the resin to the cyclooligosaccharide
(-16; Scheme 5). The approach minimizes purification steps
and the final product could be isolated in an excellent 68%
yield on the basis of the initial resin loading.
Many of the reported examples of multivalent sugar con-
structs succeed in emulating the increase in binding aﬃnity
towards specific protein receptors encountered in natural
systems. Yet, only a few of them can fully mimic the switching
between the ‘‘on’’ and ‘‘oﬀ’’ states and the regulation of the
Scheme 3 Synthesis of monosubstituted arbutin-functionalized bCD conju-
gates bearing the natural SGP branched oligosaccharide.52
Scheme 4 Nonavalent bGal-coated bCD–glycodendrimer conjugate prepared
by Seeberger and co-workers for hepatocyte-targeted drug delivery.53 Scheme 5 Solid-phase supported synthesis of CD–glycodendrimer conjugates.58
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binding intensity after an external stimulus characteristic of
carbohydrate–protein binding-mediated processes. Djedaı¨ni-
Pilard and Garcı´a Ferna´ndez et al. conceived a system based
on the ‘‘reversible structure-dependent binding’’ concept by
designing conformationally switchable glycoligands that are
sensitive to chemical inputs. They exploited the ability of
L-tyrosine moieties anchored at a primary position of bCD to
undergo self-inclusion of the aromatic ring into the CD cavity.
Installing this segment in the bridge connecting the bCD core
to a glycodendritic branch, containing either one or two copies (17)
of the branched trisaccharide 3,6-di-O-(a-D-mannopyranosyl)-a-
D-mannopyranose (Man-tri), led to formation of the corres-
ponding intramolecular complex, in which the external sugars
were not accessible to Con A lectin recognition processes. The
addition of a guest molecule having strong aﬃnity towards the
bCD cavity, e.g. an adamantane derivative, disrupted self-inclusion
and activated lectin binding capabilities.59,60 Full reversibility of
the process was proven by addition of an a,a0-trehalose-based host
(cyclotrehalan)61–66 that behaved as an adamantane scavenger,
restoring the initial state (Scheme 6). The involvement of self-
inclusion as the key step was supported by spectroscopic evidence
as well as by molecular dynamics simulations.67
2.2. Regioselectively substituted CD bis-glycoconjugates
Hattori, Yamanoi and co-workers reported the use of bCD
platforms selectively diﬀerentiated at two primary positions
in the cycloheptasaccharide to prepare a series of divalent
conjugates in which the branches are located at the a-D-gluco-
pyranosyl subunits in A and D relative disposition. In these
compounds, the distance between the two anchored glycotopes
can be modulated by varying the spacer link connecting the
external sugars and the CD core (Scheme 7).68–71 This feature
was exploited by the authors to estimate the separation between
two bGal binding sites in peanut agglutinin (PNA) lectin by
employing surface plasmon resonance (SPR). They also con-
firmed that the inclusion properties of bCD remained operative
in the bis-conjugates, using doxorubicin as a model guest. The
possibility of optimizing lectin binding and inclusion capabil-
ities illustrates the potential of the system for site-specific drug
delivery.
3. Face-selective functionalized
CD-scaﬀolded glycoclusters
The facial anisotropy of the CD platform warrants that glyco-
tope motifs in multivalent conjugates built from face-selective
functionalized precursors share an equivalent orientation and
the same space region, being ideal models to test the influence
of microclusterization in carbohydrate–protein interactions.
The use of high-yielding ligation chemistries is mandatory for
those channels in order to keep the Cn symmetry of the starting
CD. Although only a few approaches have proved compatible
with the preparation of monodisperse multiconjugates, their
high versatility provides opportunity for virtually any molecular
design that might be conceived.
3.1. Primary face-anchored ‘‘jellyfish-type’’ glycoclusters
Selective replacement of the primary hydroxyl groups in cyclo-
dextrins by halogen (I, Br) represents the most eﬃcient strategy
to access homogeneously per-(C-6)-functionalized CD deriva-
tives.72–76 The reproducibility and high yield of these trans-
formations have provided an excellent model system to test the
suitability of diﬀerent methodologies towards glycocluster
synthesis, which are itemized hereinafter. Moreover, in the
resulting ‘‘jellyfish-type’’ arrangement the wider secondary
rim of the CD platform remains open for the entrance of
suitable guests to the internal cavity, potentially retaining the
capacity for drug encapsulation and delivery.
Coupling reactions involving sulfur nucleophiles: SN2 dis-
placements and thiol–ene photoaddition reactions. In 1994
Scheme 6 CD–glycodendrimer conjugate with supramolecularly switchable
Con A binding abilities prepared by Djedaı¨ni-Pilard and co-workers.60
Scheme 7 General strategy to access bCD bis-glycoconjugates developed by
Hattori, Yamamoi and coworkers. Ether-linked and aGlc-coated divalent deriva-
tives were also prepared.68–71
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Driguez and co-workers communicated the preparation of
heptavalent CD-centred glycoclusters by SN2 displacement in
per-(C-6)-Br bCD by thiolate-functionalized fully-unprotected
galactose derivatives of all bromo groups.77 The reaction
proceeded in dimethylpropyleneurea (DMPU) at 70 1C with
moderate to good yields (50–80%) using either glycosyl thio-
lates (a and bGal) or thiol-terminated spacer-armed derivatives
(bGal) as nucleophiles (Fig. 8). Essentially the same synthetic
strategy was further implemented by the groups of Defaye and
Djedaı¨ni-Pilard78 (a and bGlc), Furuike79 and Nishimura80
(bGal, bLac, bGlcNAc, bLacNAc) to broaden the range of homo-
geneously glycocoated heptabranched conjugates. Per-(C-6)-I
bCD was alternatively used as the substrate in either DMPU
or DMF as the solvent. Interestingly, the peripheral carbo-
hydrates are susceptible for further enzymatic glycosylation
using the appropriate glycosyltransferase-sugar nucleotide-
donor pair. This chemoenzymatic approach was implemented
by Nishimura and co-workers for the synthesis of a heptavalent
array of Sialyl-LewisX (SLex) tetrasaccharide (Scheme 8).81
The above pioneering work already evidenced three impor-
tant general features of primary face-anchored multivalent
CD–glycoclusters that make them attractive candidates for
site-specific drug delivery, namely high water solubility, an
improved binding aﬃnity towards complementary lectins (e.g.
mammalian galectins for bGal derivatives),82 and encapsula-
tion capabilities that are retained for guests entering the CD
cavity through the secondary rim (e.g. prednisolone).78 Even-
tually, the incorporation of functionalized spacers between the
CD platform and the coating sugars may result in additional
interactions with an included guest following an induced-fit
process that, at its turn, may preorganize the glycotopes for
lectin recognition. Such a mechanism has been proposed by
Hattori and co-workers to account for the unexpected high
association constants of the amidolactitol-derived bGal conju-
gate 18 towards both the anticancer drugs doxorubicin (DXR)
and PNA lectin (Scheme 9).83
Purification of fully unprotected macromolecular CD conju-
gates bears considerable diﬃculty. To overcome this problem,
the groups of Santoyo-Gonza´lez, Roy and Vargas-Berenguel
favoured the use of acetylated per-(C-6)-I bCD as the substrate
and sugar thiouronium salts (bGal, bGlc, aMan, bGlcNAc, bLac)
or S-acetyl derivatives (neuraminic acid, NeuAc) as S-nucleophile
precursors. They also explored the incorporation of halogen-
armed spacers at the primary positions of the CD platform
to generate molecular diversity at the bridging segments
(Scheme 10).84–87
Extensive specific lectin recognition studies were performed
by diﬀerent techniques, including classical ELLA, two-site ELLA
(sandwich assay), turbidimetry and isothermal titration calori-
metry (ITC).86,88 It was demonstrated that the spacer arm was
not a passive element regarding lectin binding or guest inclusion.
Longer bridges often led to more eﬃcient lectin recognition,
whereas the eﬀect of persubstitution at the primary face could
be positive or detrimental for inclusion complex formation
depending on the guest partner. Thermodynamic evidence for
the formation of a ternary complex involving a heptavalent
bLac conjugate with thioacetamido linkers, PNA lectin and
2-naphthalenesulfonate was obtained, supporting an induced-
fit mechanism analogous to that depicted in Scheme 9.86
Carpenter and Nepogodiev employed per-6-thio cyclodextrins
as sulfur multinucleophiles and halogen-armed carbohydrates
as substrates for the preparation of primary face-anchored
glycoclusters, thereby reversing the location of the functional
groups involved in the key multiple SN2 reaction.
89 Per-6-thio-
aCD and -bCD (19) were obtained from the corresponding
per-(C-6)-Br and per-(C-6)-I derivatives, respectively, by reaction
with thiourea in the absence of oxygen followed by decomposition
of the resulting thiouronium salts with aqueous NaOH.90
Scheme 8 Synthesis of heptavalent bCD-centred glycoclusters from per-(C-6)-
halo derivatives by SN2 reaction with fully unprotected sugar thiolates.
Scheme 9 Guest-induced mechanism for preorganization of bGal ligands in
jellyfish-like heptavalent bCD conjugates proposed by Hattori and co-workers.83
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The fact that they are solid compounds insoluble in water
facilitated their isolation, preventing air oxidation. The corres-
ponding hexa (aCD) and heptathiolate (bCD) were subsequently
generated in DMF–water mixtures by treatment with potassium
carbonate. To test the suitability of the synthetic strategy,
4-bromoacetamidobutyl glycosides of aMan and bGlc were first
selected as reaction partners, aﬀording the corresponding
multivalent conjugates in 57–75% yield after purification by
gel permeation chromatography. The procedure was next
extended to the preparation of an heptavalent conjugate 21
incorporating the aMan-(1–3)aMan-(1–2)aMan mannotrioside
(20) as a mimic of the outer chains of the mannoproteins of
yeast (Saccharomyces cerevisiae), responsible for their allergeni-
city and antigenicity (Scheme 11).89
In the search of a high yielding and flexible synthetic
strategy to access multivalent CD-based glycoclusters, Fulton
and Stoddart investigated the photochemical addition of thiols
to allylated-bCD derivatives. Starting from heptakis(6-O-allyl-
2,3-di-O-methyl)bCD and per-O-acetylated 1-thiosugars (from
bGlc and bLac) the corresponding heptavalent conjugates were
obtained in 67 and 69% yield, respectively (Scheme 12).91,92
Homogeneity was fully established by NMR and MALDI-TOF
mass spectrometry. Molecularmodeling supported ‘‘time averaged’’
conformations with no significant deviations from the C7
symmetry. Although each carbohydrate appendage exhibited a
significant degree of freedom, they remained situated close
enough to each other to expose a highly dense patch of the
external glycotopes.91,92
Coupling reactions involving amine nucleophiles: amide,
urea, thiourea and reductive amination ligation chemistries.
Given the relevance of peptide bonds in biomolecules and the
broad availability of methods for their elaboration, attempting
the construction of CD–glycoclusters through amide-linking
strategies seemed to be a logical development. Parrot-Lopez
and Bonaly et al. reported the use of per-(C-6)-amino bCD 22,
available in two steps from per-(C-6)-halogeno precursors via
the corresponding heptaazide, for that purpose. Condensation
with the carboxylic acid-armed bGal derivative 23 was carried
out in DMF using dicyclohexylcarbodiimide (DCC) and 1-hydroxy-
benzotriazol (HOBt) as coupling reagents. The target hepta-
bGal bCD derivative 24 was thus obtained, but in a modest 35%
yield (Scheme 13).93,94 Recognition by the galactose specific
lectin from Kluyveromyces bulgaricus KbCWL was observed, but
a real cluster eﬀect could not be evidenced.
Scheme 10 Synthesis of heptavalent bCD-centred glycoclusters by nucleophilic
substitution from protected precursors.84–87
Scheme 11 Synthesis of thioether-linked hexa and heptavalent glycoclusters
from per-6-thio a- and bCD.89
Scheme 12 Synthesis of heptavalent glycoclusters by photochemical addition
of thiosugars to the per-(O-6)-allyl bCD derivative.91,92
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Heptaamine 22 and its per-(O-2,O-3)-methyl derivative have
been further employed by the groups of Hattori et al.95 and
Stoddart et al.,96 respectively, as multifunctional scaﬀolds in
the preparation of primary-face glycoclusters following essen-
tially the same approach. In all cases, the yield of the target
homogeneous heptaconjugates was handicapped by the yield of
each individual peptide coupling reaction. Inserting an spacer
between the CD core and the polyamine rim, thereby releasing
the steric strain, did not improve the eﬃciency of the multi-N-
acylation reaction.95,97 Ichikawa an co-workers98 explored the
possibility of reversing the location of the reacting functional-
ities, taking advantage of the direct oxidation of the primary
hydroxyls in native bCD with the system 2,2,6,6-tetramethyl-
pyridine 1-oxyl (TEMPO) radical-sodium perchlorate to access
the corresponding heptacarboxylic acid precursor 25. However,
further multiacylic nucleophilic reaction with amine-armed
aGal, aMan and bGlcNAc derivatives aﬀorded a distribution
of adducts with an average valency of five from which no pure
compounds were isolated (Scheme 14).
The steric constrain at the primary CD rimmight be partially
responsible for the low eﬃciency of coupling reactions invol-
ving amine or carboxylic acid. Yannakopoulou’s group
proposed the use of heptakis[6-(2-aminoethyl)amino-6-deoxy]-
bCD (26) as a multifunctional polyamine platform for the
construction of glycoclusters.97 In principle, the more accessi-
ble primary amino groups should engage preferentially in
nucleophilic addition reactions with suitable electrophiles.
The corresponding hepta-adducts would keep seven protonable
amino groups, being potentially capable of interacting with
negatively charged proteoglycans at the cell surface and impart
cell penetrating properties to the system, as already observed
for the non-glycosylated bCD precursor.99 As an alternative to
the amide-bond forming strategy, they examined the reaction of
26 with O-succinimidylcarbamate-armed glycosides (e.g. the
aMan derivative 27) to give the corresponding heptaureas (e.g.
28; Scheme 15). Nevertheless, the coupling yields remained low
(48% for 28; 19% for an analogous aGlcNAc cluster) and the
homogeneity of the conjugates could not be fully warranted.
In 1998 Garcı´a Ferna´ndez, Defaye and co-workers antici-
pated the potential of the thiourea-forming reaction for the
synthesis of multivalent CD-scaﬀolded glycoclusters.100 They
examined the reactivity of both the bCD heptaamine 22 and the
corresponding heptaisothiocyanate 29 towards per-O-acetylated
glycosyl isothiocyanates or glycosylamines, respectively. Whereas
the later protocol failed at providing C-6 heptaantennated
glycoclusters, high yields (60–80%) of the fully homogeneous
conjugates were obtained in the first case when the coupling
reactions with bGlc, bCel and bLac glycosyl isothiocyanates
were conducted in water–acetone mixtures at pH 8. Notably,
purification of the hemiacetylated adducts could be carried out
by simple column chromatography, aﬀording the pure glyco-
clusters after conventional Zemple´n deacetylation (Scheme 16).
The heptathioureas exhibited enhanced water solubility as
compared with native bCD and retained inclusion capabilities.
For instance, the water solubility of Taxote`res (0.004 g L1) was
raised up to 1.5 g L1 in a 50 mM solution of the bGlc cluster,
meaning a 350-fold increase.
The combination of molecular inclusion and multivalency
was expected to find application in site-specific drug delivery
through the formation of ternary drug:glycocluster:lectin com-
plexes. Notwithstanding, the bCD-centred heptakis(a-D-manno-
pyranosylthioureido) cluster 30 (Scheme 17) proved to be
unable to bind Con A under the ELLA test conditions, which
was ascribed to the impaired access of the convergent
Scheme 13 Amide-coupling synthesis of hepta-bGal glycocluster 24.93,94
Scheme 14 Statistical amide bond conjugation of heptacarboxylic acid–bCD 25
with amine-armed glycosides.98
Scheme 15 Urea-forming reaction in the synthesis of heptaamino-heptaman-
nosyl cluster 28. An analogous aGlcNAc-coated heptaconjugate was also pre-
pared following the same route.97
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mannosyl display to the mannose-binding sites in the lectin.101
To overcome this limitation, the incorporation of diﬀerent
spacer segments between the CD core and the polyamino
groups as well as between the glycoligands and the isothio-
cyanate functionality has been proposed. Santoyo-Gonza´lez,
Roy and co-workers implemented the use of p-isothiocyanato-
phenyl glycosides in reaction with the amino-terminated
per-(C-6)-thioalkyl derivative 31,85,86 whereas Ortiz Mellet,
Defaye, Garcı´a Ferna´ndez and coworkers coupled aliphatic
isothiocyanate-armed thioglycosides and the per-(C-6)-cysteaminyl
bCD derivative 32 as a heptanucleophile.102,103 In both cases multi-
conjugation reaction proceeded in high yield. The corresponding
hepta-aMan glycoclusters 34 and 35 exhibited Con A binding
aﬃnities according to an operative multivalent eﬀect (Scheme 17).
Glycocluster homogeneity is essential for fundamental studies
regarding multivalent carbohydrate–protein interactions. Yet, for
some practical applications statistic classical bioconjugation
methods might be acceptable. Thus, Helin and co-workers used
reductive amination to anchor the human milk tetrasaccharide
LNnT to a gCD platform partially oxidized at the primary
positions and modified by amidation with 1,3-diamino-
propane. The mixture of LNnT conjugates was enzymatically
sialylated using an a2,6-sialyltransferase to obtain the corres-
ponding sialyl-TNnT (SALNnT)-appended gCD glycoclusters
(35; Scheme 18), intended for antiadhesive therapies against
Helicobacter pylori infection.104
Coupling reactions involving alkyne derivatives: 1,3-dipolar
cycloadditions. Santoyo-Gonza´lez and co-workers pioneered
the application of 1,3-dipolar cycloadditions between diﬀerent
1,3-dipolar functions and propargyl derivatives as dipolaro-
philes for the preparation of multivalent glycoconstructs onto
CD platforms. Already in 2000 they reported a first example
consisting in the reaction of heptakis(2,3-di-O-methyl-6-O-
propargyl)bCD 36 and per-O-acetylated galactopyranosyl nitrile
oxide 37 to give the corresponding isoxazole hepta-adduct 38 in
78% yield (Scheme 19).105
In a later work, the same authors employed per-(C-6)-azido
bCD as the dipolar partner for CuAAC click multiconjugation.
The reactions with propargyl glycosides were conducted in
organic solvents with either (Ph3P)3CuBr or (Et3O)3PCuI as
Cu(I) catalyst. The simultaneous use of catalytic amounts of CuI
(10% mol) and microwave irradiation notably shortened the
reaction times. Under these conditions, the heptasubstituted
derivatives were obtained in 73–94% yield.106 The approach is
compatible with co-clicking strategies to access multifunctional
conjugates. Thus, by combining peracetylated propargyl b-D-
galactopyranoside 39 and the N-propargylated dansyl derivative
40, the corresponding fluorescently labelled multivalent
Scheme 16 Heptaglycosylthioureido-CD clusters prepared by Garcı´a Ferna´ndez,
Defaye and coworkers.100
Scheme 17 Synthesis of heptamannosylated bCD glycoclusters with diﬀerent
spacer arms and comparative Con A binding abilities.
Scheme 18 Synthesis of randomly substituted multivalent sialyl TNnT–gCD
conjugates through reductive amination.104
Scheme 19 Synthesis of an isoxazol-bridged bCD galactosyl glycocluster.105
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cyclodextrin 41 was obtained (Scheme 20). This compound was
found to act as a synthetic activator of the monocyte/macro-
phage RAW264.7 cell line by promoting cell adhesion and
production of the pro-inflammatory cytokine tumour necrosis
factor-a (TNF-a). However, comparison withmonovalent analogous
showed that this response was valency-independent.107
More recently, Compain and Ortiz Mellet et al. extended the
CuAAC methodology for the preparation of jellyfish-like bCD-
centred clusters (44, 45) in which the coating unit was the
iminosugar 1-deoxynojirimycin (DNJ), a nitrogen-in-the-ring
glycomimetic with a hydroxylation profile of structural comple-
mentarity with D-glucose. The coupling reaction involved the
heptapropargylated CD derivative 36 and the N-(o-azidoalkyl)-
DNJ derivatives 42 and 43, diﬀering in the length of the spacer,
as the alkyne and azide partners, respectively (Scheme 21).108
Evaluation of the inhibitory activity towards a panel of glycosi-
dases revealed striking multivalent eﬀects that were dependent on
both the enzyme and the glycomimetic cluster architecture. Thus,
up to 200-fold enhancements in the inhibition potency, compared
with monovalent analogues, were observed for human b-gluco-
cerebrosidase (GCase). The nonamethylene-spaced compound
was further tested for its chemical chaperone activity against
GCase mutants associated with the lysosomal storage disorder
known as Gaucher disease.109 The results indicated a GCase
activity increase of 1.6-fold in homozygous N370S fibroblasts
at 10 mM concentration of 45, which however did not represent
a significant diﬀerence with respect to a monovalent control.110
3.2. Secondary face-anchored ‘‘skirt-type’’ glycoclusters
No examples of CD-scaﬀolded glycoclusters fully decorated at
the secondary rim seem to be on record, even though eﬃcient
syntheses of suitable precursors for click-type multiconjugation
involving simultaneously the O-2 and O-3 positions have been
reported.111 Selective homogeneous functionalization of the
OH-2 or OH-3 hydroxyl groups on the secondary face of the
CDs requires prior protection of the primary hydroxyls, which is
generally accomplished by tert-butyldimethylsilyl (TBDMS)
etherification. Regioselective alkylation of the seven OH-2
groups in bCD can then be eﬀected by taking advantage of
their higher acidity as compared with the OH-3 groups, allowing
their diﬀerentiation. This reaction scheme was implemented by
Fulton and Stoddart to access the selectively per-(O-2)-allylated
bCD derivative 46, which was subsequently engaged in thiol–
ene coupling with per-O-acetylated 1-thio-b-D-glucopyranose
and 1-thio-b-lactose to aﬀord the first examples of skirt-type
CD-scaﬀolded glycoclusters 47 (Scheme 22).91,92
Vargas-Berenguel and co-workers implemented the use of
the Sonogashira cross-coupling reaction between terminal
alkynes and iodophenyl derivatives, with formation of a C–C
bond per reacting pair, to access heptavalent secondary face
aMan–bCD conjugates 51. Derivatives in which the branching
units are appended either at the O-2 or O-3 positions were
prepared starting from heptakis(3,6-di-O-tert-butyldimethylsilyl-
2-O-propargyl)bCD 48 or heptakis(2,6-di-O-benzyl-3-O-propargyl)bCD
Scheme 20 Synthesis of fluorescently labelled multivalent bGal conjugates by
co-clicking using CuAAC. The method was also applied to the preparation of
homogeneous heptavalent glycoclusters.107
Scheme 21 Click-coupling synthetic step to obtain triazolalkyl-spaced hepta-
valent glycosidase inhibitors.108,110 Scheme 22 Thiol–ene synthesis of per-(O-2)-anchored skirt-type glycoclusters.91,92
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49, respectively, upon reaction with peracetylated p-iodophenyl-
a-D-mannopyranoside 50 in the presence of catalytic amounts
of Pd(PPh3)4 and CuI in piperidine (60–66% yield). In the first
case, deprotection of the adduct involved fluorolysis of the silyl
ether groups. In the second case, hydrogenolysis removed the
benzyl protecting groups with simultaneous reduction of the triple
bonds (Scheme 23).112 The availability of per-(O-2)-propargyl-
bCD was also exploited by Santoyo-Gonzalez and co-workers to
prepare skirt-type triazol-linked bGal and bLac heptavalent con-
jugates through CuAAC using the azide-armed glycosides.107
3.3. Dual-face substituted ‘‘bouquet-type’’ glycoclusters
The much lower reactivity of the OH-3 hydroxyl groups in the CD
platform allows simultaneous regioselective alkylation at O-6 and
O-2, opening the door to the synthesis of glycoclusters in which
the appendages are symmetrically distributed in two opposite
domains, separated by the cyclooligosaccharide skeleton. Starting
from bCD, the corresponding tetradeca-O-allyl and -O-propargyl
derivatives (52 and 54, respectively) can be easily accessed in this
manner. The first one was employed as a precursor for the
preparation of tetradecavalent bGlc and bLac conjugates 53 via
thiol–ene ligation chemistry (Scheme 24).91,92 The second one was
engaged in Sonogashira cross-coupling112 or in CuAAC108 to
aﬀord the corresponding bouquet-type clusters incorporating
aMan glycotopes 55 (Scheme 24) or DNJ motifs 56, respectively
(Scheme 25). The iminosugar clicked-cluster with the C9 spacer
(56, n = 8) exhibited the highest multivalent eﬀect reported up to
date against a glycosyl hydrolase: an inhibition constant (Ki)
against Jack bean a-mannosidase of 0.022 mM was determined,
as compared with 188–204 mM for monovalent DNJ controls,
meaning a four orders of magnitude aﬃnity enhancement.108
The eﬃciency of the Sonogashira cross-coupling reaction
in multiconjugation schemes was further illustrated by
the synthesis of the 21-valent aMan conjugate 58 from
heptakis(2,3,6-tri-O-propargyl)bCD 57 (Scheme 26).112 Unfortu-
nately, no systematic evaluation of lectin binding properties
has been reported up to date for glycoclusters obtained using
this strategy.
Scheme 23 Synthesis of secondary-face substituted heptamannosylated bCD
derivatives via Sonogashira cross-coupling.112
Scheme 24 Synthesis of dual-face substituted bCD-scaﬀolded glycoclusters by
thiol–ene coupling.91,92
Scheme 25 Synthesis of ‘‘bouquet-type’’ tetradecavalent glycoclusters by
Sonogashira112 and CuAAC108 ligation chemistries.
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3.4. Hyperbranched ‘‘star-type’’ CD glycoconjugates
Multiconjugation of face-selective modified CDs with dendro-
nized branches allows increasing the total valency of the
glycoclusters keeping a symmetrical star-like arrangement
around the cyclooligosaccharide core. Not surprisingly, all
reported syntheses of hyperbranched CD glycoconjugates
involve the coupling of primary position-functionalized precursors,
readily accessible from the commercial CDs, with preformed
glycodendrons bearing a complementary functional group at
the focal point. This convergent approach warrants significant
molecular mass diﬀerences between the target fully substituted
cluster and any secondary product arising from undersubstitution,
facilitating the purification step.
Santoyo-Gonza´lez, Vargas-Berenguel and co-workers prepared
an extensive series of hyperbranched tetradecavalent glyco-
conjugates 60 bearing diﬀerent saccharidic antennae by SN2
reaction between heptakis(6-deoxy-6-iodo)bCD and thiol-armed
divalent glycodendrons 59 (Scheme 27).86,87 Hyperbranching
almost prevented the access of guest molecules to the internal
CD cavity, which was not the case for the primary face-anchored
heptavalent analogues. The higher steric hindrance imposed by
the multisaccharidic ligands, which fully block access to the
cavity through the primary rim and can partially fold down
toward the opposite secondary face, was probably at the origin
of this observation, although specific blocking of inclusion
mechanism pathways can also operate. Concerning specific
lectin recognition, a valency increase from 7 to 14 did not
implied enhanced binding aﬃnity. Surprisingly, in the case of
the tetradecavalent aMan conjugate binding to the aMan-
specific lectin Con A was fully cancelled, stressing the tremendous
impact that architectural parameters may have on carbohydrate–
lectin recognition phenomena.87
Garcı´a Ferna´ndez, Defaye, Ortiz Mellet and coworkers
exploited the thiourea-forming reaction as the key step in the
preparation of a series of 21-valent hyperbranched homo and
heteroglycoclusters with aMan, bGlc and bLac glycotopes
intended to assess the eﬀect of highly dense heterogeneous
glycoenvironments in the recognition of sugar ligands by
specific lectins.102,103,113 The isothiocyanate-armed trivalent
heteroglycodendron building blocks were synthesized by
sequential thiol–ene coupling onto triallylated pentaerythritol
followed by functional group manipulation. After conjugation
with per-(C-6)-amino bCD 22 and deacetylation of the adducts,
all combinations of (aMan)7n(bGlc or bLac)7m (m + n = 3) were
obtained (Scheme 28).
A comprehensive investigation of the binding properties
towards Con A and PNA lectins by means of diﬀerent techni-
ques, including ELLA, ITC, SPR, two-site sandwich-type ELLA
and turbidimetric assays, in comparison with low density
glycoclusters, revealed striking synergistic eﬀects. Thus, aMan
was significantly more eﬃciently recognized by Con A in the
presence of bGlc or bLac even though these sugars are not
recognized by the lectin either in low or high valency homo-
displays. Comparison of the binding avidities of tetradeca-
valent aMan–bCD conjugates having either no other sugar or
seven additional bLac units in the structure towards Con A
illustrates this fact: the Man14Lac7 heteroglycocluster exhibited
a 5-fold higher aﬃnity in a mannose molar basis. A similar
scenario was observed for bLac recognition by PNA in the
presence of aMan. This phenomenon was termed by the
authors the heterocluster eﬀect,103 its biological significance
remaining still uncertain.114
Scheme 26 Synthesis of the 21-valent ‘‘bouquet-type’’ glycocluster 58.112
Scheme 27 Synthesis of hyperbranched tetradecavalent glycoconjugates by
SN2 displacement involving sulphur nucleophiles.
86,87
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4. Multivalent CD-based supramolecular
architectures
The versatility of the CD scaﬀold allows conceiving a range of
non-covalent or mixed covalent—non-covalent multivalent archi-
tectures that broaden the potential of CD conjugates in funda-
mental as well as applied fields. The diverse examples of
multivalent CD-based supramolecular architectures, going from
bimolecular glycocomplexes to hybrid CD-biomacromolecule
glycoassemblies, are presented in the following subsections.
4.1. Supramolecular glycoclusters
Conjugation of a multivalent glycoligand and a functional ele-
ment having strong aﬃnity towards the CD cavity aﬀords multi-
valent guests that can be exploited to assemble supramolecular
glycoclusters after inclusion complex formation. In an early
example, Credi, Raymo and coworkers reported the synthesis of
amide-linked glycoferrocene conjugates 61 and 62 as redox-active
ligands for bCD.115 Monosubstituted conjugates with either a
b-D-glucopyranosyl unit or a trivalent b-D-glucopyranosyl dendron
formed 1 : 1 complexes with bCD (63 and 64) in D2O at room
temperature, with stability constants (K) of 2000 and 1300 M1,
respectively (Scheme 29). The interaction with the cyclodextrin
cavity induced changes in the electrochemical properties of the
ferrocene moiety that were used to sense the inclusion process.
The authors focused their work on the possibility of using
carbohydrate substitution and inclusion complex formation to
protect the ferrocene core from solvent interactions or from
interactions with an electrode or a partner in an encountered
complex. Although the results illustrate the potential of the CD
inclusion capabilities for designing multivalent supramolecular
architectures, this aspect was someway disregarded at that time.
Further work by the group of Vargas-Berenguel deepened on
the characterization of glycoferrocene–bCD complexes.116
Divalent 1,10-bis(glycosyl)ferrocenes bearing b-D-glucopyranosyl
(bGlc), a-D-mannopyranosyl (aMan) and b-lactosyl (bLac) residues
(65 and 66) were synthesized by either thioglycosylation or
copper(I)-catalysed alkyne–azide cycloaddition (CuAAC) ligation
chemistries. The association constants with bCD were determined
from calorimetric and voltammetric titration experiments both in
their neutral and oxidised forms. A main conclusion of this work
was that the disubstituted ferrocene derivatives formed stable
complexes with bCD through inclusion of the ferrocene core into
the cyclodextrin cavity. Whereas for monovalent conjugates the
ferrocene moiety adopts an axial orientation, as shown in
Scheme 29, in the case of the 1,10-disubstituted derivatives it
adopts an equatorial disposition in the supramolecular complex
(Fig. 5). In no case rotaxane-type complexes, i.e., complexes having
the ferrocene moiety axially oriented inside the cavity with the
sugar units protruding from opposite faces, were formed. The
potential of these systems to probe multivalent carbohydrate–
protein interactions by electrochemical techniques was men-
tioned by the authors, but no data seem to be available up to date.
In the above commented cases, the valency of the 1 : 1
inclusion complex system is already defined by the valency of
the guest glycoconjugate. If the CD host already bears a sugar
ligand, inclusion complex formation will produce a supra-
molecular homoglycocluster with increased formal valency if
both guest and host are substituted by the same saccharide
motif and a heteroglycocluster if they are diﬀerent. An example
of this approach has been reported by Hayashida and Hamachi
using a cyclophane platform modified with three b-D-galacto-
pyranosyl (bGal) substituents and a dansyl group (67), responsible
Scheme 28 Synthesis and general structure of bCD-scaﬀolded hyperbranched
homo and heteroglycoclusters by thiourea-forming reactions.102,103,113
Scheme 29 Supramolecular glycoferrocene–CD conjugates.115
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for the fluorescence of the molecule and well-adapted to inclu-
sion in the bCD cavity.117 This conjugate formed heterodimers
(69) with 6-O-b-D-glucopyranosyl- and 6-O-maltosyl-bCD (68) with
K values of 770 and 600 M1, respectively (Scheme 30). The
ability of the dansyl-labelled trivalent galactocyclophane guest to
bind specifically to peanut agglutinin (PNA) was confirmed by
turbidimetry and fluorescence techniques. The high versatility of
the preparation method, that involves just mixing the comple-
mentary partners, makes it suitable for assembling supra-
molecular clusters having various kinds of sugar residues with
a well-defined chemical structure and stoichiometry.
The combination of CD conjugates and complementary
multitopic guests represents an alternative strategy to assemble
supramolecular complexes with increased formal valency. The
potential of this approach to improve the aﬃnity of a CD-
centered glycocluster towards specific lectins was first pointed
out by Defaye, Garcı´a Ferna´ndez, Ortiz Mellet and co-workers in
the frame of a project aiming at developing site-specific delivery
systems for the taxane anticancer drug docetaxel (Taxote`res).47
They observed clusterization of tri- and hexa-mannosyl dendron–
bCD conjugates in the presence of the drug through formation
of 1 : 2 inclusion complexes implying the aromatic rings in the
docetaxel molecule (e.g. 70), which translated into enhanced
binding aﬃnity towards Con A (Fig. 6).
More recently, Seeberger and coworkers have extended the
concept of guest-promoted clusterization of multivalent CD con-
jugates to assemble fluorescent sensors with varied architectures.118
The multivalent supramolecules are comprised of a fluorescent
ruthenium(II) core functionalized with 2, 4 or 6 adamantyl units (71)
that act as anchor elements for bCD conjugates. Heptavalent
glycoclusters in which the bCD platform was homogeneously
substituted at the primary C-6 positions with 2-(a-D-mannopyrano-
syloxy)ethylthio branches (72) were self-assembled onto this core to
form complexes exposing 14, 28 or 42 mannopyranosyl units (73)
with a unique spatial orientation (Scheme 31). These systems
proved to be very well-suited to probe the structural requirements
for eﬃcient binding to immobilized Con A as a function of lectin
density by surface plasmon resonance (SPR). Additionally, the
inherent red fluorescence of the Ru(II)-containing supramolecular
clusters allowed direct visualization of their association with E. coli
(strain ORN178), expressing wild-type mannose-binding FimH
lectin in the pili, by confocal microscopy. The possibility of tuning
the saccharide ligands, the cluster valency and the supramolecular
spatial arrangement in a very flexible system provides a streamline
method to generate collections of multivalent probes.
4.2. Multivalent polyrotaxane glycodiplays
Polyrotaxanes are supramolecular assemblies consisting of
several cyclic compounds threaded onto linear polymeric
Fig. 5 Example of a divalent supramolecular conjugate based on a glycoferro-
cene–bCD inclusion complex (left) and structure of the diglycosylated ferrocene
derivatives prepared by Vargas-Berenguel and co-workers.116
Scheme 30 Glycocyclophane–glycobCD supramolecular multivalent hetero-
dimers.117
Fig. 6 Docetaxel (in blue)-promoted clusterization of hexamannosylated glyco-
dendritic bCD conjugates.47
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chains capped with bulky end-groups. If the capping groups are
missing, therefore allowing dethreading processes to take
place, the term pseudopolyrotaxane is used. The most charac-
teristic feature of these ‘‘beads-on-a-string’’ dynamic systems is
that the cyclic components can spin around the axes of the
polymer as well as move back and forth along the polymer
chain. The cavity of cyclodextrins, particularly of aCD and
bCD, has been shown to be well adapted to pseudopolyrotaxane
formation with linear polymers119–121 such as poly-
(ethylene glycol) (PEG), poly(propylene glycol) (PPG) or
poly(tetrahydrofuran) (PTHF).122 If the CD beads are part of a
glycoconjugate, then a ‘‘mobile’’ display of the coating sugar
ligand is obtained, with the potential to self-fit the inter-
saccharide distance and orientation in the presence of a given
receptor partner for an optimal interaction (Fig. 7A). Alterna-
tively, threading CD ‘‘beads’’ onto a glycopolymer ‘‘string’’ can
be exploited to modulate the dynamic properties of the polymer
backbone and, likewise, influence the molecular recognition
behaviour of the supramolecular system (Fig. 7B).
With the aim to investigate how ligand mobility aﬀects
multivalent interactions, Yui and co-workers prepared a series
of maltose–aCD–polyrotaxane (Mal–aCD–PRXs) conjugates by
sequential (i) rotaxanation of aCD onto a,o-diamino-PEG
(Mn = 4000) (74), (ii) condensation with N-benzyloxycarbonyl
(Z)-protected L-tyrosine (Z-TyrOH), thereby capping polyrotaxane
ends, (iii) reaction of the resulting polyrotaxane with succinic
anhydride to convert all primary OH groups in the aCD units
into the corresponding 2-carboxyethyl esters (-75) and (iv)
statistic incorporation of b-maltosylamine (76) through amide
bond-forming reaction (-77; Scheme 32).123–125 Structural
variability was introduced based on the CD threading percen-
tage (22, 38 or 53%; corresponding to 50, 85 or 120 aCD beads
per polymer string) and the maltose conjugation degree (from
0.4 to 3 Mal units per aCD bead, meaning from 42 to 244 Mal
ligands per polyrotaxane supramolecule). Glyco-PRXs with
diﬀerent CD loads and glycosyl units per CD but similar
amounts of total maltose were thus obtained.
Scheme 31 Ru(II)-centred supramolecular multivalent mannosides prepared by
Seeberger and co-workers; the 42-valent construct is shown.118
Fig. 7 Schematic representation of multivalent polyrotaxane glycodisplays
based on CD-conjugates (A) and on glycopolymer–CD polyrotaxane hybrids (B).
The mobile character of both types of supramolecular constructs is indicated.
Scheme 32 Synthesis of maltose–aCD–polyrotaxanes according to Yui and
co-workers.123–125
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A systematic evaluation of the binding aﬃnity of the Mal–
aCD–PRXs against Con A was carried out by hemagglutination
inhibition assay. Maltose, an unthreaded aCD derivative bear-
ing three maltosyl substituents and maltose-poly(acrylic acid)
glycopolymers bearing 42, 55, 117 or 240 bMal units per
polymer chain were used as standards for comparative pur-
poses. The results revealed that in the case of polyrotaxanes
bearing 50 or 85 aCD beads per PEG chain, the lectin binding
aﬃnity increased with the number of Mal units, whereas for the
most heavily charged Mal–aCD–PRX, with 120 aCD beads per
chain, as well as for the glycopolymers, a maximum in aﬃnity
was reached when 117 Mal units were exposed, then decreasing
dramatically for higher Mal densities. The authors interpreted
these results in terms of optimal mobility for the first con-
structs that allows maximizing binding while minimizing steric
mismatching upon lectin aggregation. Experimental evidence
to support this hypothesis was obtained initially by Raman
spectroscopy126 and further confirmed by advanced NMR
studies.125 The relatively high mobility of the Mal ligand in
the rotaxane architecture additionally prevents the formation of
ordered clusters of water molecules, avoiding the unfavourable
energy term derived from breaking those clusters upon lectin
binding.
In 2010, Sasabe and coworkers extended Yui’s approach for
the synthesis of multivalent Z-protected tyrosine-capped glyco-
polyrotaxanes for the preparation of Mal–aCD–PRXs immobi-
lized onto polystyrene (PS) microspheres (1–50 mm), with an
average load of five maltosyl groups per aCD threaded unit
(78, Scheme 33).127 The interaction between the glycoparticles
and biotinylated Con A was studied by fluorescence microscopy
employing a quantum dot–streptavidin (QD–SV) conjugate. The
red fluorescence observed at 655 nm suggested specific recog-
nition of the maltosyl moieties by the lectin. It should be noted,
however, that the aCD polyrotaxane itself, prior to Mal conju-
gation, also elicited a Con A-dependent weak response in
this assay.
Nelson and Stoddart implemented an alternative strategy to
multivalent pseudopolyrotaxane preparation that employed
monovalent, therefore monodisperse, amide-linked bLac–CD
conjugates as the initial threading components.128 Rotaxana-
tion of the aCD derivative 79 onto bis-3-aminopropyl-
terminated PTHF (Mn = 1100) was first considered, but the
system was found to be unstable in water solution, precipitat-
ing on standing. This problem could be avoided using instead
the per-(O-2,O-6)-methylated bCD conjugate 80, which threaded
onto bis-3-aminopropyl-terminated PTHF (81) or bis-2-amino-
propyl-terminated PPG (Mn = 2000) to aﬀord dynamic water-
soluble pseudopolyrotaxanes (Scheme 34). Unfortunately, the
threading/dethreading of the CDs was fast on the 1H NMR
timescale to the extent that isolating the pseudopolyrotaxanes
was not possible, preventing lectin binding evaluation studies.
In order to lower the rate of translational motion of the CD
beads along the polymer chain of pseudopolyrotaxanes, the
same laboratory investigated the use of polycationic polyvio-
logen AB-copolymers (82), comprising alternating decamethy-
lene segments and positively charged bipyridinium moieties as
strings. The authors hypothesized that the mono-Lac–aCD
conjugate 79 should thread onto the polymer chain in aqueous
solution and rest preferentially on the hydrophobic deca-
methylene segments (83), which was confirmed by 1H NMR
Scheme 33 Mal–aCD–PRX-coated polystyrene microspheres.127
Scheme 34 Schematic representation of multilactosylated pseudorotaxane
assembling from monolactosylated CD conjugates.128
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spectroscopy, whereas the cationic aromatic moieties should
act as electronic ‘‘speed bumps’’ (Scheme 35).129
Interestingly, the threading percentage could be determined
for diﬀerent pseudo-PRX constructs, varying in the polyviolo-
gen chain length (average number of repeating units 8, 17 or
21) and in the initial Lac–bCD conjugate : polyviologen ratio by
using the Bradford assay, towards which the ‘‘uncovered’’
polymer was sensitive.130 The resulting supramolecular species
were challenged for their ability to inhibit agglutination of
T-cells induced by recombinant human galectin-1 (Gal-1), a
ditopic lactose-recognizing lectin involved in tumor develop-
ment, as well as in quantitative Gal-1 precipitation assays.129,131
Valency corrected binding enhancements up to 30-fold over
native lactose in the agglutination assay were observed, with
pseudo-PRX : Gal-1 ratios close to 1 : 1 in the quantitative
precipitation assay and binding aﬃnity enhancements per
rotaxanated polymer that tend to increase in a statistic manner
with the number of Lac recognition motifs. The results were
compatible with a one-to-one binding mechanism in which
only one of the lactoside-binding sites is occupied at a time.
Nevertheless, deviations from the statistic trend for PRX pre-
pared from the longer polyviologen chains (21 repeating units)
with the lower Lac–CD load (one forth of the theoretical full
coverage), leading to the highest per-lactose binding enhance-
ments, suggested that chelation also operates. Most probably,
the dynamic character of multivalent PRXs allows a variety of
binding modes with the lectin whose distribution changes with
the degree of threading (Fig. 8).
In 2009, Fort and co-workers re-investigated the potential of
using a monoLac–aCD conjugate 84 to aﬀord multiLac neogly-
coconjugates 87 through rotaxanation, taking advantage of the
aﬃnity of the aCD cavity towards linear decamethylene seg-
ments.132 The authors implemented CuAAC ‘‘click’’ chemistry
to incorporate the lactosyl glycotope onto the aCD beads as well
as at the end of the terminal repeating unit of the oligomer
string. The same ligation chemistry was further used to connect
the clickable oligorotaxane portions (85 and 86), after inclusion
complex formation, to ensemble the target mechanically
interlocked multivalent system. A main advantage of the
approach is that the density of lactosyl moieties can be eﬃ-
ciently controlled by adjusting the excess of the monoLac–aCD
host before clicking (Scheme 36).
The resulting oligorotaxanes were evaluated as inhibitors of
asialofetuin–PNA binding by ELLA. The lectin binding aﬃnity
clearly improved with valency. However, if the interaction is
analyzed on a lactosyl unit basis, only a 2 to 4-fold improvement
is achieved, meaning a rather modest multivalent eﬀect. Insuf-
ficient mobility of the threaded cyclodextrin conjugates to allow
an optimal complementarity between the displayed Lac units
and the lectin binding sites may be at the origin of this result.
Nevertheless, it must be noted that, in the absence of the
chelate eﬀect, ELLA is considered to provide information about
multivalent ligands and a single binding site of the lectin. In
such a scenario, sliding of recognition motifs over the binding
site and rebinding eﬀects are usually the predominant mecha-
nisms at work, which might not be particularly favoured in the
polyrotaxane architecture.
Dong and co-workers conceived a completely diﬀerent type of
multivalent CD-based pseudopolyrotaxane architecture consisting
of a glycosylated triblock copolymer, with two edge blocksmade of
poly(D-gluconamidoethylmethacrylate) (PGAMA) separated by a
poly(e-caprolactone) pseudopolyrotaxane (PPR) threaded with
native aCD.133 (Fig. 9). In this particular construct, the CD motif
acts by masking the crystallinity of the biodegradable poly-
(e-caprolactone) block, thereby preventing precipitation of the
glycopolymer. The compounds were found to self-assemble spon-
taneously in water, with critical aggregation concentrations
between 46.1 and 51.2 mg mL1. DLS and TEM studies showed
spherical micellar aggregates with 81–121 nm radius, where the
central PPR segments adopted a channel type structure. Specific
interactions with Con A were evidenced by the formation of bigger
aggregates, in the mm range, in the presence of the lectin, leading
the authors to conclude that these new biohybrids might found
broad application in targeted drug delivery.
Scheme 35 Schematic representation of polyviologen (n = 8, 17 or 21)-
bLac–aCD pseudorotaxane neoglycoconjugates 83 with translational restricted
mobility.129
Fig. 8 Possible binding mechanism for two Gal-1 lectin molecules and two
multilactosylated polypseudorotaxane chains.129
Review Article Chem Soc Rev
Pu
bl
ish
ed
 o
n 
23
 Ja
nu
ar
y 
20
13
. D
ow
nl
oa
de
d 
by
 C
en
tro
 d
e 
In
ve
sti
ga
ci
on
es
 C
ie
nt
ifi
ca
s I
sla
 d
e 
la
 C
ar
tu
ja 
(C
IC
IC
) o
n 2
5/0
6/2
01
4 0
8:3
4:2
4. 
View Article Online
4764 Chem. Soc. Rev., 2013, 42, 4746--4773 This journal is c The Royal Society of Chemistry 2013
4.3. Self-assembled glycocoated liposomes, micelles and
vesicles based on amphiphilic CDs
Chemical modification at one or both rims of CD platforms has
been largely exploited to achieve amphiphilic derivatives with
the capability of self-assembling into nanoparticles or lipo-
somes that can be loaded with drugs.134 Endowing those
systems with targeting properties has been a main motivation
for the development of glycoamphiphilic CD (GaCD) con-
structs. In 2004 Sallas, Niikura and Nishimura reported the
first representatives of this new family of compounds.135 Start-
ing from per-(C-6)-azido-bCD, the corresponding tetradeca-
(O-2,O-3)-palmitoyl derivative 88 was first prepared by reaction
with palmitoyl anhydride and 4-(N,N-dimethylamino)pyridine
in anhydrous pyridine, though in modest (40%) yield.
Transformation of the azido groups into isocyanate or
amine functionalities allowed subsequent installation of
2-acetamido-2-deoxy-b-D-glucopyranosyl (bGlcNAc) units 89
and 90 through urea- (short arm) or amide-forming reactions
(long arm) (Scheme 37). None of the amphiphilic glycoclusters
91 and 92 thus prepared was water-soluble, but they could be
incorporated into liposomes by using 1 : 9 mixtures with
dioleyl phosphatidylcholine (DOPC). The accessibility of the
coating monosaccharide residues to protein partners was
assessed by monitoring the reaction with b(1–4)galactosyltrans-
ferase and UDP-Gal. In the case of the liposomes prepared from
the shorter-arm GaCD derivative 91, a single galactopyranosyl
residue per GaCD cluster was incorporated, whereas for the
longer-arm counterpart 92 a mixture of diﬀerently substituted
compounds was observed by MALDI-TOF mass spectrometry
In principle, self-assembling of GaCDs should lead to a
multivalent presentation of the glycotopes attached to the CD
core even in the case of monosubstituted derivatives. With this
idea in mind, Parrot-Lopez and coworkers conceived the synth-
esis of a GaCD derivative containing a single bGal antenna at
the C-6 position and lipophilic hexanoyl groups at the O-2 and
O-3 positions.136 The synthetic route implied protection of the
primary hydroxyl groups in (C-6)-monoazido-bCD as the corres-
ponding tert-butyldimethylsilyl (TBDMS) ethers, followed by
acylation of the secondary hydroxyls with hexanoic anhydride
and DMAP in pyridine (66% yield). Catalytic hydrogenation of
the azido group and amide condensation of the resulting
monoamine 93 with a carboxylic acid-armed bGal derivative
94 aﬀorded the target conjugate 95, for which its ability to form
stable Langmuir films was demonstrated (Scheme 38).
The groups of Darcy and Mazzaglia developed a novel
prototype of GaCDs in which the hydrophobic tails are installed
Scheme 36 Synthesis of multilactosylated polyrotaxanes by CuAAC.132
Fig. 9 Glycopolymer–pseudopolyrotaxane biohybrids.133
Scheme 37 Synthesis of multivalent liposomes from glycoamphiphilic
cyclodextrins.135
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at the primary face of the bCD platform and the glycosyl
residues at the secondary rim, a ‘‘jellyfish-type’’ arrange-
ment.137 The synthetic approach benefits from the well-
established eﬃciency of the nucleophilic displacement of
(C-6)-bromo groups by thiolate to introduce alkylthio chains
of diﬀerent length, followed by etherification of the more acidic
OH-2 groups with ethylene carbonate. This latter reaction
creates a new cluster of seven primary hydroxyls (96) that were
selectively brominated (97) by reaction with triphenyl-
phosphine/N-bromosuccinimide in DMF. A second multiple
nucleophilic displacement round, using now sugar thiolates
as nucleophiles, aﬀorded a set of thioether-linked GaCDs
98.138,139 Alternatively, the primary hydroxyls in the key
precursor 96 can be reacted with glycosyl isothiocyanates to
give heptaconjugates in which the glycotopes are linked to the
CD core through thiocarbamoyl bridges (Scheme 39).140
While the synthetic approach is very flexible, it sacrifices
homogeneity and symmetry by aﬀording a polydisperse mixture
of heptavalent compounds in which the spacer between the
coating sugar and the bCD core can contain a variable number
of oxyethylene fragments (average two). Nevertheless, the
mixtures were shown to self-organize in water solution after
sonication to provide either small micelles (B4 nm) or nano-
spheres (20–30 nm), that eventually aggregated into larger
objects (500–600 nm), or vesicles (100–200 nm). The first trend
was preferentially observed for GaCDs bearing hexylthio chains
at the hydrophobic domain, whereas hexadecylthio tails favoured
the formation of vesicular structures (Scheme 40).137–140
The presence of an aqueous compartment both in micellar
aggregates and vesicles was evidenced by encapsulation of the
fluorescent dye Rhodamine 6G. In any case, a multivalent
display of the sugar epitope at the surface of the nanoobject
is expected. Binding to specific lectins was investigated by
fluorescence techniques, taking advantage of the modification
of the triptophane emission after complex formation. In the
case of hexylthio conjugates, specific recognition of bGal-coated
micellar aggregates by the lectin PA-I from Pseudomonas
aeruginosa136–139 and of aMan- and bFuc-modified analogues
by Lens culinaris LcH lectin140 was demonstrated. Unexpectedly,
selective interactions of vesicles formulated from hexadecyl
Scheme 38 Synthesis of a mono-bGal amphiphilic bCD 95 and schematic
representation of its self-association into multivalent Langmuir films.136
Scheme 39 Synthesis and schematic representations of ‘‘jellyfish-type’’ GaCDs 98.140
Scheme 40 Schematic representation of the self-assembling processes of
‘‘jellyfish-like’’ GaCDs.137–140
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GaCDs exposing the same glycotopes could not be ascertained.
The authors argued that binding can be hindered in this case
by the vesicular architecture, but a more rigorous analysis
would require the implementation of alternative evaluation
techniques.
The approach based on (C-6)-thioalkylation followed by
(O-2)-etherification with ethylene carbonate, prior to glyco-
conjugation, gives rise to amphiphilic bCD derivatives with a
high tendency to self-organize into unilamellar vesicles in water.
These CD vesicles exposed the hydrophilic secondary face, the
wider entry to the internal cavity, to the external environment.
This feature was exploited by Ravoo and coworkers to install
glycoligands at the vesicle surface through supramolecular
ligation, taking advantage of the high aﬃnity of the bCD cavity
towards adamantane moieties.141 Thus, they prepared b-malto-
side (Mal) and b-lactoside (Lac) tetraethyleneglycol–adamantane
conjugates (99, 100) and studied their association with CD
vesicles obtained from the dodecylthio amphiphilic bCD deriva-
tive 101 by ITC (Fig. 10). Association constants of 4.4  104 M1
and 4.0 104 M1 for 99 and 100, respectively, were determined,
with a very favourable entropic term.
Optical density (400 nm) and DLS studies of the sugar-
decorated nanovesicles in the presence of Con A and PNA
lectins evidenced the presence of aggregates for those ternary
systems where the CD vesicles were present in conjunction with
matching pairs of sugar ligand/lectin, i.e.Mal/Con A or Lac/PNA
(Scheme 41). No aggregation occurred in any other case,
demonstrating the specificity of the interaction and the need
for a multivalent presentation.141,142
4.4. Biomacromolecule-cyclodextrin multivalent assemblies
Multivalent cyclodextrin conjugates are susceptible to interact
with biomacromolecules (proteins, nucleic acids) through, e.g.,
encapsulation of hydrophobic moieties into the CD cavity or
electrostatic interactions, to form supramolecular assemblies.
Eventually, poly(CD-conjugate)–biomacromolecule complex
formation may lead to profound changes in the structure and
physicochemical properties of the biomacromolecular partner,
often resulting in increased stability in biological media. The
glycosyl residues in the CD conjugate exert a notable influence in
this process. Moreover, upon self-assembling their presentation
mode is also drastically aﬀected, generally leading to increased
glycotope densities and, consequently, to enhanced aﬃnities
towards lectin receptor partners. The potential of this concept
for site-specific delivery of biomacromolecular drugs has spurred
intense research in the field in the last few years.143–146
In 2006, Uekama and coworkers reported the stabilization of
lysozyme and basic fibroblast growth factor by a series of CD
derivatives including (O-6)-maltosyl a, b and gCD (Mal–CD),
being the bCD derivative specially eﬃcient (Fig. 11).147 The
authors rationalized the result in terms of the better fitting of
aromatic amino acid residues inside the bCD cavity, favoring
the formation of poly(Mal–bCD):protein inclusion complexes.
Complexation was actually found to destabilize the native
conformation of the protein, favouring a partially unfolded
state. The maltosyl substituents exerted a decisive role in
preventing interactions with other protein molecules and
avoiding the formation of aggregates. This behaviour is con-
sistent with their exposure to the environment, which should
make them accessible for lectin recognition events. In spite of
the appealingness of the strategy for glycotargeted protein
delivery, no research in that direction seems to have been
communicated so far.
Fig. 10 Amphiphilic CD 101 and glycoadamantyl conjugates 99 and 100
prepared by Ravoo and coworkers (top) and schematic illustration of the multi-
valent glycovesicles formed by supramolecular ligation.141
Scheme 41 Schematic representation of the aggregation of Lac–CD vesicles
with PNA lectin. An analogous process was observed for Mal–CD vesicles with
Con A.141,142
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The increasing awareness of the potential of polycationic CD
derivatives in the design of nonviral gene delivery systems has
led several groups to explore the suitability of polycationic CD
conjugates to impart, simultaneously, stability and targeting
capabilities of the corresponding complexes with plasmid DNA
(pDNA), for which the term CDplexes has been coined.148–157
Uekama, Arima and co-workers conceived a series of multi-
functional CD conjugates consisting of a poly(amidoamine)
(PAMAM) starburst dendrimer 102 onto which one-to-two
aCD units (103) were randomly attached through a single
primary (C-6) position by reaction with the corresponding 6I-
tosyl derivative 103. Some of the remaining primary amino
groups of the dendrimer were subsequently engaged in
thiourea forming reactions with isothiocyanate-armed aMan
(104) and aGal derivatives to aﬀord the corresponding poly-
cationic aCD–PAMAM glycoconjugates. Second (G2) and third
(G3) generation PAMAM derivatives (105) with diﬀerent sub-
stitution degrees of either aMan or bGal motifs were thus
prepared (Scheme 42).158–166
In the presence of pDNA, the G2 and G3 aCD–PAMAM
conjugates formed nanocomplexes (glycoCDplexes; 200–400 nm)
whose stability was dependent on the coating sugar substitu-
tion degree (Scheme 43). In general, replacement of PAMAM
amino groups by glyco-thiourea moieties was detrimental
regarding DNA compaction and protection abilities. However,
enhanced serum-resistant transfection capabilities were
encountered in several cell lines after optimization of the aMan
or aGal loading. Thus, the G3 aMan–aCD–PAMAM system with
a substitution degree of 10 sugar units per dendrimer was as
eﬃcient as the aCD–PAMAM unglycosylated vector, but with a
much more favorable toxicity profile. Unexpectedly, the trans-
fection properties were independent of the expression or not of
specific aMan receptors at the cell surface. Competition experi-
ments revealed that, even though receptor-mediated internali-
zation did not operate, the multivalent aMan display at the
surface of the glycoCDplexes imparted endosome escaping,
traﬃcking and nuclear localization abilities, which might arise
from interactions with intracellular lectins.165,166
The inability of the aMan-coated CDplexes formulated with
aMan–aCD–PAMAM conjugates to elicit specific internalization
in macrophages, expressing the macrophage mannose receptor
(MMR) at their surface, might arise from impaired accessibility
of the aMan residues to participate in molecular recognition
events. Actually, SPR experiments indicated a rather low aﬃnity
of these constructs towards Con A. The corresponding aGal-
coated CDplexes similarly behaved as broad range transfection
systems, with no selectivity for cell lines expressing Gal-specific
lectins such as the asialoglycoprotein receptor (ASGPr) at the
Fig. 11 Schematic representation of the poly(maltosyl-bCD):protein complexes
reported by Uekama and co-workers.147
Scheme 42 Synthesis of aMan–aCD–PAMAM (G2 and G3) conjugates prepared
by Uekama and coworkers. Conjugates incorporating aGal instead of aMan units
were analogously prepared.158–166
Scheme 43 Schematic representation of glycoCDplex formation from aMan–
aCD–PAMAM conjugates and plasmid DNA.165,166
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cell surface of hepatocytes. Looking for constructs well-suited
for site-specific gene delivery, direct conjugation of aCD–
PAMAM with lactose through reductive amination, to give
Lac–aCD–PAMAM conjugates, was next considered (Fig. 12).
In this case, the bGal-coated nanoparticles obtained after
glycoCDplex formulation exhibited high aﬃnity towards PNA
lectin and enhanced hepatocyte (HepG2 cell line) binding
ability as compared with non-galactosylated vectors, as
evidenced by SPR and flow cytometry, respectively. Both
Lac–aCD–PMAM (G2) and (G3) reported high and selective hepa-
tocyte transfection levels, with no appreciable cytotoxicity.163,164
In vivo studies with the G2 glycoconjugate revealed enhanced
transfection in the liver and higher biocompatibility than the
commercial reference compound JetPEIt-Hepatocyte.163
In the frame of a collaborative project aiming at developing
CD-based molecular systems for site-specific gene delivery,
Garcı´a Ferna´ndez, Ortiz Mellet, Vierling and Defaye et al.
proposed a new multivalent vector prototype (108), character-
ized by incorporating (i) a cluster of alternated amino groups
and glycosyl units at the primary rim of the bCD platform and
(ii) a multitail hydrophobic domain at the secondary face
(Scheme 44).167 The synthesis followed a convergent scheme
involving, as the key step, the multi-thiourea coupling reaction
of an isothiocyanate-armed bifunctional dendritic element
bearing an aMan residue and a Boc-protected amino group
(106) with the per-(C-6)-cysteaminyl-per-(O-2,O-3)-hexanoyl bCD
derivative 107. Final carbamate hydrolysis aﬀorded the target
C7-symmetric aMan-coated polycationic glycoamphiphilic CD
(pGaCD) 108 in 70% yield.
The aMan–pGaCD derivative was found to self-assemble in
the presence of pDNA to give nanometric glycoCDplexes (hydro-
dynamic radius 80 nm) with positive z-potential (40 mV). The
accessibility of the aMan glycotopes at the surface of the
nanoparticles to lectin binding events was confirmed by ELLA
using Con A as well as recombinant human MMR (rhMMR)
lectins. Adhesion to macrophages was also evaluated in vitro
using a fluorescently labelled plasmid. The data indicated that
binding specificity was dependent on the vector : pDNA ratio
used for glycoCDplex formulation. At a protonable nitrogen/
phosphorous (N/P) ratio of 10, nonspecific binding, probably
due to electrostatic interactions with negatively charged pro-
teoglycans at the cell surface, competed with MMR-mediated
binding, but the latter was largely predominant at N/P 5
(Scheme 45). Using this formulation, selective macrophage
internalization was achieved as evidenced by fluorescent acti-
vated cell sorting (FACS), leading to macrophage-specific
transfection.167
Statistic incorporation of biorecognizable glycotopes onto a
polycationic amphiphilic cyclodextrin (paCD) platform repre-
sents an alternative strategy to impart targeting abilities to
molecular CD-based gene vectors. In principle, the pDNA com-
plexing and lectin binding abilities could be optimized by
varying the proportion of the coating sugar. Rejman, Garcı´a
Ferna´ndez and co-workers explored this approach for the
preparation of bGal-coated pGaCDs (111) intended for hepato-
cyte-specific nucleic acid delivery.168 Since replacement of
cationic centres by sugar motifs in paCDs was detrimental for
CDplex stability, grouping the recognition elements into multi-
valent glycodendrons prior to paCD conjugation was judged
convenient. The coating moiety consisted of a trivalent b-D-
galactopyranosyl antenna, built on a pentaerythritol scaﬀold,
armed with an isothiocyanate group (110) for thiourea-forming
conjugation. A tetradecacationic dendritic paCD (109) that
already had proven to be highly eﬃcient as gene vector was
Fig. 12 Lactosylated aCD–PAMAM conjugates (the G3 generation with an aCD
loading of 2 and a Lac substitution degree of 3 is shown), obtained by reductive
amination, for hepatocyte-specific gene delivery.163,164
Scheme 44 Synthesis of the aMan–pGaCD gene vector prototype proposed by
Garcı´a Ferna´ndez and co-workers.167
Chem Soc Rev Review Article
Pu
bl
ish
ed
 o
n 
23
 Ja
nu
ar
y 
20
13
. D
ow
nl
oa
de
d 
by
 C
en
tro
 d
e 
In
ve
sti
ga
ci
on
es
 C
ie
nt
ifi
ca
s I
sla
 d
e 
la
 C
ar
tu
ja 
(C
IC
IC
) o
n 2
5/0
6/2
01
4 0
8:3
4:2
4. 
View Article Online
This journal is c The Royal Society of Chemistry 2013 Chem. Soc. Rev., 2013, 42, 4746--4773 4769
chosen as the polyamine partner. Insertion of poly-
(ethyleneglycol) chains between the glycodendrons and the
CD core was additionally considered to improve the bioavail-
ability of the system (Scheme 46).
The bGal-coated polycationic glycoamphiphilic CDs formed
stable glycoCDplexes with pDNA and mRNA that were inter-
nalized by HepG2 cells through specific interactions with the
asialoglycoprotein receptor. Competition experiments demonstrated
that the complexes escaped from the endosomal compartments
and released the nucleic acid material into the cytosol. Deceiv-
ingly, very low transfection levels were achieved in the case of
pDNA, which is consistent with recent results of O’Driscoll and
co-workers in a related family of galactosylated CD vectors.169
The experimental evidence suggested that the nuclear envelop
represented the major barrier for eﬃcient pDNA transfection
with pGaCDs 111. The fact that high transfection levels were
achieved with mRNA, which is translated in the cytoplasm,
much higher as compared with mRNA complexes formulated
with the reference compound JetPEIt-Hepatocyte, supported
this assumption.168
5. Conclusions and perspectives
The increasing awareness of the importance of multivalency in
carbohydrate recognition and the number of unanswered
questions regarding the mechanisms at work warrants
sustained fundamental research in this topic in the following
years. In any case, it is now well-established that multivalency
amplifies and modulates the biological information encoded by
carbohydrates.170,171 Taking full advantage of this notion
requires suitable supports capable of presenting the code signs
to the reader partner in a proper manner. Cyclodextrins have
largely demonstrated their suitability for those channels. The
functional character of the CD scaﬀold further allows exploiting
this knowledge to interfere, control or program carbohydrate
binding to biological receptors. By taking advantage of the
inclusion capabilities of CDs, receptor-targeted molecular
delivery can be achieved through the guest:multivalent
CD:lectin ternary complex formation provided that the corres-
ponding supramolecular processes exhibit appropriate equili-
brium constants. The magnitude of apparent stability
constants for several drug:CD complexes, K in M1, ranges
from 0 to 105, the value of K1:1 being most often between 50 and
2000 M1.172–174 Higher stability constants may lead to drug
sequestering.175 Regarding aﬃnity towards therapeutically
useful lectins, association constants in the mM to nM range,
which can generally be achieved by exploiting multivalency,
may warrant eﬃcient glycotargeting by eliciting receptor-
mediated internalization mechanisms.176 Although hydrophilic
cyclodextrins are considered nontoxic at low to moderate oral
dosages, parenteral administration may involve toxicity issues
that need to be investigated in depth.174 Chemical tailoring can
be further put forward to promote the formation of glyco-
micelles, films, vesicles or nanoparticles for sensing, diagnos-
ing or biomacromolecule transport. New developments will
certainly arise in the near future from the intimate merging
of multivalency, supramolecular chemistry and nanotechnology
through the cyclodextrin connection.
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Scheme 45 Schematic representation of aMan-glycoCDplex formation by self-
assembling of aMan–pGaCD in the presence of pDNA, with indication of the two
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glycoCDplexes after self-association in the presence of pDNA or mRNA.168
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